Urocortin-2 suppression of p38-MAPK signaling as an additional mechanism for ischemic cardioprotection

Sensitization of melanoma cells for TRAIL-induced apoptosis by BMS-345541 correlates with altered phosphorylation and activation of Bax

(2013) A Berger et al.   Cell Death & Disease

Comparative pharmacokinetics and pharmacodynamics of urocortins 1, 2 and 3 in healthy sheep

(2012) K Patel et al.   BRITISH JOURNAL OF PHARMACOLOGY

New Therapeutic Targets in Cardiology

(2012) Eva Denise Martin et al.   CIRCULATION

Baicalein protects Human melanocytes from H2O2-induced apoptosis via inhibiting mitochondria-dependent caspase activation and the p38 MAPK pathway

(2012) Bangmin Liu et al.   FREE RADICAL BIOLOGY AND MEDICINE

Chloroacetic acid induced neuronal cells death through oxidative stress-mediated p38-MAPK activation pathway regulated mitochondria-dependent apoptotic signals

(2012) Chun-Hung Chen et al.   TOXICOLOGY

Translocation and oligomerization of Bax is regulated independently by activation of p38 MAPK and caspase-2 during MN9D dopaminergic neurodegeneration

(2011) Chang-Ki Oh et al.   APOPTOSIS

The functions of mTOR in ischemic diseases

(2011) Seo-Kyoung Hwang et al.   BMB Reports

The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy

(2011) P N Kelly et al.   CELL DEATH AND DIFFERENTIATION

A novel cardioprotective p38-MAPK/mTOR pathway

(2011) Gonzalo Hernández et al.   EXPERIMENTAL CELL RESEARCH

Corticotropin-releasing factor family and its receptors: pro-inflammatory or anti-inflammatory targets in the periphery?

(2011) Huayuan Zhu et al.   INFLAMMATION RESEARCH

Measuring mitochondrial function in intact cardiac myocytes

(2011) Elena N. Dedkova et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

2-Methoxyestradiol induced bax phosphorylation and apoptosis in human retinoblastoma cells via p38 MAPK activation

(2011) Hongbo Min et al.   MOLECULAR CARCINOGENESIS

Acute effects of urocortin 2 on cardiac function and propensity for arrhythmias in an animal model of hypertension-induced left ventricular hypertrophy and heart failure

(2010) Silvia Meili-Butz et al.   EUROPEAN JOURNAL OF HEART FAILURE

New targets of urocortin-mediated cardioprotection

(2010) Seán P Barry et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Activation of Src protein tyrosine kinase plays an essential role in urocortin-mediated cardioprotection

(2010) Zhaokan Yuan et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Urocortin induced expression of COX-2 and ICAM-1 via corticotrophin-releasing factor type 2 receptor in rat aortic endothelial cells

(2009) Rongjian Zhang et al.   BRITISH JOURNAL OF PHARMACOLOGY

MCL-1–dependent leukemia cells are more sensitive to chemotherapy than BCL-2–dependent counterparts

(2009) Joslyn K. Brunelle et al.   JOURNAL OF CELL BIOLOGY

Control of mitochondrial apoptosis by the Bcl-2 family

(2009) J. K. Brunelle et al.   JOURNAL OF CELL SCIENCE

Urocortin induces interleukin-6 release from rat cardiomyocytes through p38 MAP kinase, ERK and NF-κB activation

(2009) Man Huang et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Corticotropin releasing factor-induced ERK phosphorylation in AtT20 cells occurs via a cAMP-dependent mechanism requiring EPAC2

(2009) Kristof Van Kolen et al.   NEUROPHARMACOLOGY

The Role of the Ubiquitin Proteasome System in Ischemia and Ischemic Tolerance

(2009) Robert Meller   NEUROSCIENTIST

AMPK, MAPK and Bax in the heart: some questions answered

(2008) Vilmante Borutaite   BIOCHEMICAL JOURNAL

Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure

(2008) Miriam T. Rademaker et al.   CLINICAL SCIENCE

Low carbohydrate diet decreases myocardial insulin signaling and increases susceptibility to myocardial ischemia

(2008) Peipei Wang et al.   LIFE SCIENCES